Sanofi in Ireland
We have over 800 people working every day to serve those with health needs in Ireland and around the world. Wherever the team members are based, we all share the values of Teamwork, Integrity, Courage and Respect and our common purpose: Empowering Life.
Our manufacturing campus in Waterford has more than 740 skilled people working across multiple products and platforms, supplying therapies to people in over 70 countries. We continue to expand, providing opportunities for people to join the team, and help us support our No1 stakeholders; the people we provide our medicines for.
Our dedicated team based out of Dublin bring a broad range of treatments to people across Ireland. Amongst our treatments we have consumer healthcare, vaccines, and medicines for cardiovascular disease, diabetes, multiple sclerosis, thrombosis, rare diseases and atopic dermatitis.
Transparency in our interactions
Collaborations with healthcare professionals (HCPs) and healthcare organisations contribute significantly to our efforts to improve the quality of patient care, benefitting individuals and society at large. For more information, including our annual breakdown of transfer of value to patient associations, click here.
Committing to our communities
For the Irish team, Corporate Social Responsibility is about being good neighbours in the communities where we work and live.
The Waterford team support a range of programmes to promote study and careers in STEM (science, technology, engineering and maths) subjects and is a long-standing partner of Junior Achievement Ireland who unite business and education. We also champion diversity, through Sanofi Future Female Leaders Scholarships, and play an active role in the Waterford community, most notably taking part in the city’s renowned international street theatre festival with the Sanofi Spraoi Orchestra.
As well as supporting various causes in the community around our Citywest base, the Dublin team work closely with CMRF Crumlin who support Our Lady’s Children’s Hospital and the National Children’s Research Centre.
Valproate Educational materials
These materials contain important information about the risks associated with valproate (Epilim▼) in female children, women of childbearing potential and pregnant women. They were developed in agreement with the Health Products Regulatory Authority (HPRA) and are available to healthcare professionals and patients.
▼This medicinal product is subject to additional monitoring.
Suspected side effects should be reported to HPRA Pharmacovigilance at www.hpra.ie (information about reporting side effects).
You can also report side effects directly to Sanofi on IEPharmacovigilance@sanofi.com or + 353 1 403 5600.
You can contact our medical information team for further information at IE-Medicalinformation@sanofi.com or + 353 1 403 5600.